The use of cardiac troponin-I to determine the incidence of myocardial injury in patients with acute stroke;Myokardskade ved akutte hjerneslag bedømt med troponin I

Tidsskrift for den Norske Laegeforening

Volumn 121, Issue 4, 2001, Pages 421-425

  Troøyen, Morten ^a   Indredavik, Bent ^b   Rossvoll, Ole ^b   Slørdahl, Stig A ^c  

^a Det medisinske fakultet   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c Norges Teknisk NU   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TROPONIN I;

ACUTE DISEASE; AGED; ARTICLE; BLOOD; CEREBROVASCULAR ACCIDENT; DAILY LIFE ACTIVITY; ENZYMOLOGY; FEMALE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MIDDLE AGED; PATHOLOGY;

ACTIVITIES OF DAILY LIVING; ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; TROPONIN I;

EID: 0035835719     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ellekjær H, Holmen J, Indredavik B, Terent A. Epidemiology of stroke in Innherred, Norway, 1994 to 1996. Incidence and 30-day case-fatality rate. Stroke 1997; 28: 2180-4.
2. Slørdahl SA, Skjærpe T, Indredavik B. Hjerneslag og hjertet. Konsekvenser av et hjemeslag på hjertet. Hjerteforum 1999; 12: 84-93.
3. Indredavik B, Slørdahl SA, Bakke F, Rokseth R, Håheim LL. Stroke unit treatment, long-term effects. Stroke 1997; 28: 1861-6.
4. Indredavik B, Bakke F, Solberg R, Rokseth R, Haaheim LL, Holme I. Benefit of a stroke unit: a randomized controlled trial. Stroke 1991; 22: 1026-31.
5. Abildskov JA, Millar K, Burgess MJ, Vincent W. The electrocardiogram and the central nervous system. Prog Cardiovasc Dis 1970; 13: 210-6.
6. Connor RCR. Heart damage associated with intracranial lesions. BMJ 1968; 3: 29-31.
7. Norris JW, Hachinski VC, Myers MG, Callow J, Wong T, Moore RW. Serum cardiac enzymes in stroke. Stroke 1979; 10: 548-53.
8. Daae LNW, Andreassen T, Mehus LL, von der Lippe A, Ørjavik O. Måling av troponin I-nivå ved mistanke om hjerteinfarkt. Tidsskr Nor Lægeforen 1999; 119: 3887-9.
9. Apple FS. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. Clin Chem Acta 1999; 284: 151-9.
10. Chapelle JP. Cardiac troponin I and troponin T: recent players in the field of myocardial markers. Clin Chem Lab Med 1999; 37: 11-20.
11. Mahoney F, Barthel D. Functional evaluation: the Barthel index. Md Med J 1965; 14: 615.
12. Horowitz MB, Willet D, Keffer J. The use of cardiac troponin I (cTnI) to determine the incidence of myocardial ischemia and injury in patients with aneurysmal and presumed aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 1998; 140: 87-93.
13. Kolin A, Norris JW. Myocardial damage from acute cerebral lesions. Stroke 1984; 15: 990-3.
14. Oppenheimer SM, Cechetto DF, Hachinski VC. Cerebrogenic cardiac arrhytmias: cerebral electrocardiographic influences and their role in sudden death. Arch Neurol 1990; 47: 513-9.
15. Goldstein DS. The EKG in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke 1979; 10: 253-9.
16. McNair JL, Clower BR, Sanford RA. The effect of reserpine pretreatment on myocardial damage associated with stimulated intracranial hemorrhage in mice. Eur J Pharmacol 1970; 9: 1-6.
17. Lindahl B, Gerhardt W. Biokemiska markörer kan ge tidig diagnos av myokardskada. Läkartidningen 1998; 95: 3034-8.
18. Panteghini M. Biochemical assessment of myocardial damage with new diagnostic tools. Cardiologia 1999; 44: 419-25.
19. Slørdahl S, Indredavik B. Akutt hjerneslag. Pasienter behandlet ved slagenheten i Trondheim. Tidsskr Nor Lægeforen 1996; 116: 1452-4.
20. Whicher J, Biasucci L, Rifai N. Inflammation, the acute phase response and atherosclerosis. Clin Chem Lab Med 1999; 37: 495-503.